483
Biocon Generics Inc.Biocon Generics Inc. – FDA 483, Oct 10, 2025
Record Details
During an inspection of Biocon Generics Inc. in Cranbury, NJ, the FDA observed a significant issue regarding the firm's adherence to warehousing procedures for drug products. Specifically, the logbook for temperature and humidity monitoring in the drug product storage area lacked required personnel and reviewer signatures. This indicates a failure to follow established SOPs for data recording and verification.
- Person
View Company Profile
ID · 1810204b-2279-456f-9a53-fd8f96c59fe3
Other documents for Biocon Generics Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.